Rekombinanter CA9 (Girentuximab Biosimilar) Antikörper
Kurzübersicht für Rekombinanter CA9 (Girentuximab Biosimilar) Antikörper (ABIN7093059)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Verwendungszweck
- Anti-CA9 (girentuximab biosimilar) mAb
-
Produktmerkmale
- WX-G250, cG250
-
Aufreinigung
- Purified from cell culture supernatant by affinity chromatography
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- ELISA 1:5000-10000, Flow Cyt 1:100
-
Kommentare
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Reconstitute with deionized water
-
Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
-
Haltbarkeit
- 12 months
-
-
- CA9 (Girentuximab Biosimilar)
-
Substanzklasse
- Biosimilar
-
Hintergrund
- Synonyms: CAIX, MN
-
Gen-ID
- 768
-
UniProt
- Q16790
Target
-